Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. The company is headquartered in Cambridge, Massachusetts and currently employs 6 full-time employees. The firm is focused on using cutting-edge gene-editing tools to deliver safe off-the-shelf cell therapies for the treatment of advanced solid tumors. Its Pipeline includes ERNA-101, and ERNA-102. Its core technology utilizes engineer allogenic-induced pluripotent stem cells (iPSCs) to express genes of interest and to efficiently differentiate these cells into mesenchymal stem cells (iMSCs). The firm seeks to capitalize on the intrinsic tumor-homing ability of MSCs to slip through the tumor’s defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment (TME), thus unleashing potent anti-cancer immune responses. The firm is focused on developing iPSC-derived iMSC that express critical factors, such as pro-inflammatory cytokines.
Sur la base des 6 analystes attribuant des notes à l'action ERNA, mis à jour le Mar 01, 2023
Sell
Strong buy
0
Buy
0
Hold
3
Sell
1
Strong sell
2
Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for ERNA. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: ERNA is a Sell candidate.
ERNA stock price ended at $1.21 on Vendredi, after rising 2.54%
On the latest trading day Jan 16, 2026, the stock price of ERNA rose by 2.54%, climbing from $1.20 to $1.21. Throughout the session, the stock experienced a volatility of 6.03%, with prices fluctuating between a daily low of $1.16 and a high of $1.23. Alongside this price increase, trading volume also rose by 24.8K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 30.5K shares were traded, amounting to a market value of approximately $9.4M.
Signaux Techniques de ERNA
Résumé des Signaux Techniques
Acheter des signaux 2
Signaux neutres 2
Signaux de vente 3
Strong Sell
Sell
Neutral
Buy
Strong Buy
ERNA présente actuellement 2 signaux d'achat et 3 signaux de vente. L'action est en tendance haussière depuis 12:00 AM, avec une variation totale du prix de 2.54% pendant cette période. En général, les indicateurs techniques indiquent une tendance Sell à moyen terme.
Signaux haussiers/baissiers pour ERNA
Nous analysons les indicateurs clés comme les moyennes mobiles, le RSI, le MACD et le volume de transactions pour générer des signaux haussiers et baissiers pour ERNA, vous aidant à prendre des décisions d'investissement éclairées.
Questions complémentaires
Comment les indicateurs d'analyse technique s'appliquent-ils à ERNA ?
Quels sont les niveaux de retracement de Fibonacci pour ERNA ?
Quel est le RSI de Ernexa Therapeutics Inc ?
Quel est le prix de Ernexa Therapeutics Inc pour les 12 prochains mois ?